$2.17
-0.18 (-7.66%) today
Galectin Therapeutics Inc (GALT) is up 64.39% over the past year but down 15.23% over the past month, trading at $2.17.
Price · today
Key stats
Market cap$143M
Day high$2.38
Day low$2.17
Day open$2.36
Prev close$2.35
ExchangeNASDAQ NMS - GLOBAL MARKET
Performance · all intervals
1D
-7.66%
1W
+3.33%
1M
-15.23%
3M
-21.38%
6M
-60.62%
YTD
-47.84%
1Y
+64.39%
5Y
-50.46%
ALL
-87.94%
Green vs red closes
Last 1D
0up1down
0% green
Last 1W
3up2down
60% green
Last 1M
9up12down
43% green
Last 3M
29up33down
47% green
Last 6M
55up65down
46% green
Year to date
39up52down
43% green
Last 1Y
122up120down
50% green
Last 5Y
568up622down
48% green
Custom Interval
Pick any window — not just the presets above.
days
Related stocks
Compare GALT with
Latest news on GALT
Galectin Therapeutics Q1 EPS $(0.08) Misses $(0.06) Estimate
Benzinga·22h ago
Galectin Therapeutics Reports March 31, 2026 Financial Results and Provides Business Update
Finnhub·22h ago
Galectin Therapeutics Inc Announces Publication of Navigate Phase 2B Trial Results for Belapectin
Finnhub·4d ago
Galectin Therapeutics announces publication of Navigate phase 2b trial results for belapectin in the Journal of Hepatology
Finnhub·4d ago
Galectin Therapeutics Announces Publication Of Results From NAVIGATE Phase 2b Clinical Trial Evaluating Belapectin In Patients With MASH Cirrhosis And Portal Hypertension In AASLD Flagship Journal Hepatology
Benzinga·4d ago
Reserved